These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30944188)

  • 1. Ultrasensitive Detection of Clostridium difficile Toxins Reveals Suboptimal Accuracy of Toxin Gene Cycle Thresholds for Toxin Predictions.
    Sandlund J; Wilcox MH
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30944188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Clinical Specificity with Ultrasensitive Detection of Clostridioides difficile Toxins: Reduction of Overdiagnosis Compared to Nucleic Acid Amplification Tests.
    Sandlund J; Estis J; Katzenbach P; Nolan N; Hinson K; Herres J; Pero T; Peterson G; Schumaker JM; Stevig C; Warren R; West T; Chow SK
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434726
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.
    Sandlund J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Bishop JJ; Nolan N; Estis J; Todd J; Young S; Senchyna F; Banaei N
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30158195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pitfalls of laboratory diagnostics of Clostridium difficile infection.
    Krutova M; Wilcox MH; Kuijper EJ
    Clin Microbiol Infect; 2018 Jul; 24(7):682-683. PubMed ID: 29505883
    [No Abstract]   [Full Text] [Related]  

  • 5. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection.
    Wilcox MH
    Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():13-20. PubMed ID: 23121550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens.
    Shin BM; Yoo SM; Shin WC
    Ann Lab Med; 2016 Mar; 36(2):131-7. PubMed ID: 26709260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of laboratory tests for detection for Clostridioides difficile: A multicenter prospective study in Japan.
    Senoh M; Kato H; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
    Anaerobe; 2019 Dec; 60():102107. PubMed ID: 31647977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Clostridium difficile toxin genes by PCR: sequence variation may cause false-negative results.
    Cao B; Zhang Y; Bian F; Cheng Y; Wang J; Jia H; Zhang W; Lu J; Chen C; Du P
    J Med Microbiol; 2015 Feb; 64(Pt 2):195-197. PubMed ID: 25480881
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of poor outcome in Clostridioides difficile infection: A multicentre external validation of the toxin B amplification cycle.
    Reigadas E; Alcalá L; Marín M; Martin A; Muñoz P; Bouza E;
    Anaerobe; 2020 Feb; 61():102079. PubMed ID: 31356959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes.
    Hitchcock MM; Holubar M; Hogan CA; Tompkins LS; Banaei N
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31511334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
    Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
    Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of Single-Molecule Array Assays for Detection of Clostridium difficile Toxins in Comparison to Conventional Laboratory Testing Algorithms.
    Banz A; Lantz A; Riou B; Foussadier A; Miller M; Davies K; Wilcox M
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29898996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic pitfalls in Clostridium difficile infection.
    Planche T; Wilcox MH
    Infect Dis Clin North Am; 2015 Mar; 29(1):63-82. PubMed ID: 25595842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Qiagen artus C. difficile QS-RGQ Kit for Detection of Clostridium difficile Toxins A and B in Clinical Stool Specimens.
    Jazmati N; Wiegel P; Ličanin B; Plum G
    J Clin Microbiol; 2015 Jun; 53(6):1942-4. PubMed ID: 25809977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of
    Kraft CS; Parrott JS; Cornish NE; Rubinstein ML; Weissfeld AS; McNult P; Nachamkin I; Humphries RM; Kirn TJ; Dien Bard J; Lutgring JD; Gullett JC; Bittencourt CE; Benson S; Bobenchik AM; Sautter RL; Baselski V; Atlas MC; Marlowe EM; Miller NS; Fischer M; Richter SS; Gilligan P; Snyder JW
    Clin Microbiol Rev; 2019 Jun; 32(3):. PubMed ID: 31142497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic Acid Amplification Test Quantitation as Predictor of Toxin Presence in Clostridium difficile Infection.
    Crobach MJT; Duszenko N; Terveer EM; Verduin CM; Kuijper EJ
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29237788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples.
    Stahlmann J; Schönberg M; Herrmann M; von Müller L
    Clin Microbiol Infect; 2014 Sep; 20(9):O590-2. PubMed ID: 24450741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.
    Terveer EM; Crobach MJ; Sanders IM; Vos MC; Verduin CM; Kuijper EJ
    J Clin Microbiol; 2017 Feb; 55(2):403-411. PubMed ID: 27852676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy.
    Sandlund J; Davies K; Wilcox MH
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32269098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxin A-negative, toxin B-positive Clostridium difficile infection diagnosed by polymerase chain reaction.
    Cheng Y; Du P; Chen C; Yan S; Jia H; Wang J; Yan Q; Feng H; Lu J
    Infect Control Hosp Epidemiol; 2011 May; 32(5):520-2. PubMed ID: 21515990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.